Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden.

about

Introduction of the second-generation direct-acting antivirals (DAAs) in chronic hepatitis C: a register-based study in Sweden.

P2860

Q52597394-61215B35-3FEA-46CF-8C85-1F0DDA68EDE6

P2860

Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden.

Item

http://www.wikidata.org/entity/Q40550798

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Prevalence and comorbidities o ...... ased register study in Sweden.

@en

type

Item

label

Prevalence and comorbidities o ...... ased register study in Sweden.

@en

prefLabel

Prevalence and comorbidities o ...... ased register study in Sweden.

@en

P1476

Prevalence and comorbidities o ...... ased register study in Sweden.

@en

P2093

Ann-Sofi Duberg

http://www.w3.org/2001/XMLSchema#string

Jan Kövamees

http://www.w3.org/2001/XMLSchema#string

Jesper Waldenström

http://www.w3.org/2001/XMLSchema#string

Jonas Söderholm

http://www.w3.org/2001/XMLSchema#string

Katharina Büsch

http://www.w3.org/2001/XMLSchema#string

Martin Lagging

http://www.w3.org/2001/XMLSchema#string

Soo Aleman

http://www.w3.org/2001/XMLSchema#string

P2860

Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes

The natural history of hepatitis C virus (HCV) infection.

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C

IP-10 predicts viral response and therapeutic outcome in difficult-to-treat patients with HCV genotype 1 infection

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence

Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data.

External review and validation of the Swedish national inpatient register.

The completeness of the Swedish Cancer Register: a sample survey for year 1998.

P304

61-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00365521.2016.1228119

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ola Weiland

P577

2016-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27598393

http://www.w3.org/2001/XMLSchema#string

P921

An t-Suain

Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden.

about

P2860

P2860

Prevalence and comorbidities of chronic hepatitis C: a nationwide population-based register study in Sweden.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921